Cargando…

Dose‐Dependent Carbon‐Dot‐Induced ROS Promote Uveal Melanoma Cell Tumorigenicity via Activation of mTOR Signaling and Glutamine Metabolism

Uveal melanoma (UM) is the most common intraocular malignant tumor in adults and has a low survival rate following metastasis; it is derived from melanocytes susceptible to reactive oxygen species (ROS). Carbon dot (Cdot) nanoparticles are a promising tool in cancer detection and therapy due to thei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Yi, Yu, Jie, Chen, Xingyu, Wang, Shaoyun, Tu, Zhaoxu, Shen, Guangxia, Wang, Huixue, Jia, Renbing, Ge, Shengfang, Ruan, Jing, Leong, Kam W., Fan, Xianqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061404/ https://www.ncbi.nlm.nih.gov/pubmed/33898168 http://dx.doi.org/10.1002/advs.202002404

Ejemplares similares

SKP2 targeted inhibition suppresses human uveal melanoma progression by blocking ubiquitylation of p27
por: Zhao, Hongbo, et al.
Publicado: (2019)

Uveal melanoma: progress in molecular biology and therapeutics
por: Li, Yongyun, et al.
Publicado: (2020)

Epigenetic drug library screening reveals targeting DOT1L abrogates NAD(+) synthesis by reprogramming H3K79 methylation in uveal melanoma
por: Gu, Xiang, et al.
Publicado: (2023)

Role of Epigenetics in Uveal Melanoma
por: Li, Yongyun, et al.
Publicado: (2017)

A Novel Stimuli‐Responsive Injectable Antibacterial Hydrogel to Achieve Synergetic Photothermal/Gene‐Targeted Therapy towards Uveal Melanoma
por: Wang, Shaoyun, et al.
Publicado: (2021)

Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis
por: Chai, Peiwei, et al.
Publicado: (2018)

Targeting histone deacetylase suppresses tumor growth through eliciting METTL14‐modified m(6)A RNA methylation in ocular melanoma
por: Zhuang, Ai, et al.
Publicado: (2023)

The Long Non-Coding RNA RHPN1-AS1 Promotes Uveal Melanoma Progression
por: Lu, Linna, et al.
Publicado: (2017)

Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth
por: Han, Anna, et al.
Publicado: (2023)

Long Non-coding RNA LINC-PINT Suppresses Cell Proliferation and Migration of Melanoma via Recruiting EZH2
por: Xu, Yangfan, et al.
Publicado: (2019)

The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma
por: Zhang, Leilei, et al.
Publicado: (2018)

ROS, Klotho and mTOR in cardiorenal aging
por: Daneshgar, Nastaran, et al.
Publicado: (2020)

Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression
por: Wu, Mingsong, et al.
Publicado: (2015)

Publication trends of research on uveal melanoma during 2000–2020: a 20-year bibliometric study
por: Xie, Minyue, et al.
Publicado: (2020)

An Artificial CTCF Peptide Triggers Efficient Therapeutic Efficacy in Ocular Melanoma
por: Wen, Xuyang, et al.
Publicado: (2020)

Glutamine deprivation stimulates mTOR-JNK-dependent chemokine secretion
por: Shanware, Naval P., et al.
Publicado: (2014)

LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter
por: Ni, Hongyan, et al.
Publicado: (2020)

Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma
por: Yu, Jie, et al.
Publicado: (2021)

Glutamine Availability Regulates the Development of Aging Mediated by mTOR Signaling and Autophagy
por: Zhou, Jiao, et al.
Publicado: (2022)

Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype
por: Ho, Alan L., et al.
Publicado: (2012)

Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis
por: Chai, Peiwei, et al.
Publicado: (2020)

Targeted Silencing of MART-1 Gene Expression by RNA Interference Enhances the Migration Ability of Uveal Melanoma Cells
por: Zhang, Yidan, et al.
Publicado: (2013)

Metformin promotes histone deacetylation of optineurin and suppresses tumour growth through autophagy inhibition in ocular melanoma
por: Zhuang, Ai, et al.
Publicado: (2022)

Therapeutic Efficacy by Targeting Correction of Notch1-Induced Aberrants in Uveal Tumors
por: Huang, Xiaolin, et al.
Publicado: (2012)

Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway
por: Yuan, Lingqin, et al.
Publicado: (2015)

Additive effects of inhibiting both mTOR and glutamine metabolism on the arthritis in SKG mice
por: Ueda, Yo, et al.
Publicado: (2019)

Early Reconstruction Surgery Resolving Visual Occlusion and Ocular Malformation: A Case Report
por: Xu, Shiqiong, et al.
Publicado: (2014)

CDC20 Knockdown and Acidic Microenvironment Collaboratively Promote Tumorigenesis through Inhibiting Autophagy and Apoptosis
por: Gu, Qingying, et al.
Publicado: (2020)

The Pharmacological NF-κB Inhibitor BAY11-7082 Induces Cell Apoptosis and Inhibits the Migration of Human Uveal Melanoma Cells
por: Hu, Shuiqing, et al.
Publicado: (2012)

Sperm-Specific Glycolysis Enzyme Glyceraldehyde-3-Phosphate Dehydrogenase Regulated by Transcription Factor SOX10 to Promote Uveal Melanoma Tumorigenesis
por: Ding, Xia, et al.
Publicado: (2021)

The general amino acid control pathway regulates mTOR and autophagy during serum/glutamine starvation
por: Chen, Rui, et al.
Publicado: (2014)

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
por: Feng, Mengyu, et al.
Publicado: (2018)

Inhibition of the glutamine transporter SNAT1 confers neuroprotection in mice by modulating the mTOR-autophagy system
por: Yamada, Daisuke, et al.
Publicado: (2019)

The glutamine antagonist prodrug JHU-083 slows malignant glioma growth and disrupts mTOR signaling
por: Yamashita, Alex Shimura, et al.
Publicado: (2020)

Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
por: Ge, Tongxin, et al.
Publicado: (2022)

Knockdown of CLN5 inhibits the tumorigenic properties of glioblastoma cells via the Akt/mTOR signaling pathway
por: Xing, Jiexia, et al.
Publicado: (2021)

Nuclear PD-L1 promotes EGR1-mediated angiogenesis and accelerates tumorigenesis
por: Yu, Jie, et al.
Publicado: (2023)

Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors
por: Yim, Kein-Leong
Publicado: (2012)

PTK6 inhibits autophagy to promote uveal melanoma tumorigenesis by binding to SOCS3 and regulating mTOR phosphorylation
por: Liu, Bo, et al.
Publicado: (2023)

mTOR and ROS regulation by anethole on adipogenic differentiation in human mesenchymal stem cells
por: Rhee, Yun-Hee, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7ku2cnneu469hlucova3kr7hgu